• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miRNAs 在结直肠癌的诊断、预后和治疗中的作用。

MiRNAs roles in the diagnosis, prognosis and treatment of colorectal cancer.

机构信息

11th Department of Medical Oncology, "Iuliu Hatieganu" University of Medicine and Pharmacy , Cluj-Napoca , Romania.

Medical Oncology Department, Institute of Oncology "Prof. Ion Chiricuta" , Cluj-Napoca , Romania.

出版信息

Expert Rev Proteomics. 2019 Oct;16(10):851-856. doi: 10.1080/14789450.2019.1659732. Epub 2019 Aug 29.

DOI:10.1080/14789450.2019.1659732
PMID:31446809
Abstract

: The liver is the main location for metastasization in stage IV colorectal cancers. : This review intends to comprehensively present the most important studies conducted in the past few years concerning the role of miRNAs in colorectal cancer liver metastases, trying to clarify some aspects regarding tumor biology and favorite liver metastasization site. : Recent advances in tissue and serum RNA extraction has considerably improved the field of microRNAs studies. These molecules known to play a crucial role in the metastatic stage indicate a starting point in the development of clinical biomarkers with a possible role in the stratification of high-risk patients for adequate treatment.

摘要

肝脏是 IV 期结直肠癌转移的主要部位。本综述旨在全面介绍过去几年中关于 miRNAs 在结直肠癌肝转移中作用的最重要研究,试图阐明肿瘤生物学和首选肝转移部位的一些方面。组织和血清 RNA 提取的最新进展极大地促进了 microRNAs 研究领域的发展。这些已知在转移阶段发挥关键作用的分子为开发具有适当治疗高危患者分层作用的临床生物标志物提供了一个起点。

相似文献

1
MiRNAs roles in the diagnosis, prognosis and treatment of colorectal cancer.miRNAs 在结直肠癌的诊断、预后和治疗中的作用。
Expert Rev Proteomics. 2019 Oct;16(10):851-856. doi: 10.1080/14789450.2019.1659732. Epub 2019 Aug 29.
2
Role of MicroRNA in the Diagnosis and Therapy of Hepatic Metastases from Colorectal Cancer.微小RNA在结直肠癌肝转移诊断与治疗中的作用
Microrna. 2018;7(3):167-177. doi: 10.2174/2211536607666180525073302.
3
[Use of micro RNAs in the diagnosis and prognosis of colorectal cancer (CCR)].[微小RNA在结直肠癌诊断和预后中的应用(CCR)]
Gac Med Mex. 2016 May-Jun;152(3):386-96.
4
MicroRNAs as novel biomarkers for colorectal cancer: New outlooks.微小 RNA 作为结直肠癌的新型生物标志物:新展望。
Biomed Pharmacother. 2018 Jan;97:1319-1330. doi: 10.1016/j.biopha.2017.11.046. Epub 2017 Nov 14.
5
Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis.用于结直肠癌诊断和预后的新兴 microRNA 生物标志物。
Open Biol. 2019 Jan 31;9(1):180212. doi: 10.1098/rsob.180212.
6
MicroRNAs: Potential candidates for diagnosis and treatment of colorectal cancer.微小RNA:结直肠癌诊断与治疗的潜在候选物
J Cell Physiol. 2018 Feb;233(2):901-913. doi: 10.1002/jcp.25801. Epub 2017 May 15.
7
Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives.结直肠癌中下调的 microRNAs:诊断和治疗视角。
BMB Rep. 2018 Nov;51(11):563-571. doi: 10.5483/BMBRep.2018.51.11.116.
8
The Impact of miRNA in Colorectal Cancer Progression and Its Liver Metastases.miRNA 在结直肠癌进展及其肝转移中的作用。
Int J Mol Sci. 2018 Nov 22;19(12):3711. doi: 10.3390/ijms19123711.
9
MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.微小 RNA 与结直肠癌的预后和治疗:从基础到临床。
World J Gastroenterol. 2018 Jul 21;24(27):2949-2973. doi: 10.3748/wjg.v24.i27.2949.
10
MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy.微小RNA作为辅助结直肠癌患者分层及指导治疗的工具。
Pharmacogenomics. 2017 Jul;18(10):1027-1038. doi: 10.2217/pgs-2017-0004. Epub 2017 Jun 22.

引用本文的文献

1
Blood miRNAs miR-549a, miR-552, and miR-592 serve as potential disease-specific panels to diagnose colorectal cancer.血液中的微小RNA miR-549a、miR-552和miR-592可作为诊断结直肠癌的潜在疾病特异性指标。
Heliyon. 2024 Mar 24;10(7):e28492. doi: 10.1016/j.heliyon.2024.e28492. eCollection 2024 Apr 15.
2
CircXRN2 accelerates colorectal cancer progression through regulating miR-149-5p/MACC1 axis and EMT.环状 RNA XRN2 通过调控 miR-149-5p/MACC1 轴和 EMT 促进结直肠癌进展。
Sci Rep. 2024 Jan 30;14(1):2448. doi: 10.1038/s41598-024-52257-3.
3
Hsa_circ_0003602 Contributes to the Progression of Colorectal Cancer by Mediating the miR-149-5p/SLC38A1 Axis.
Hsa_circ_0003602 通过介导 miR-149-5p/SLC38A1 轴促进结直肠癌的进展。
Gut Liver. 2023 Mar 15;17(2):267-279. doi: 10.5009/gnl210542. Epub 2022 Sep 23.
4
Analysis of miR-143, miR-1, miR-210 and let-7e Expression in Colorectal Cancer in Relation to Histopathological Features.分析 miR-143、miR-1、miR-210 和 let-7e 在结直肠癌中与组织病理学特征的关系。
Genes (Basel). 2022 May 13;13(5):875. doi: 10.3390/genes13050875.
5
MiR-1306-5p predicts favorable prognosis and inhibits proliferation, migration, and invasion of colorectal cancer cells via PI3K/AKT/mTOR pathway.miR-1306-5p 通过 PI3K/AKT/mTOR 通路预测结直肠癌细胞的预后良好,并抑制其增殖、迁移和侵袭。
Cell Cycle. 2022 Jul;21(14):1491-1501. doi: 10.1080/15384101.2022.2054245. Epub 2022 Apr 13.
6
Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.环状 RNA 蛋白酪氨酸激酶 2(circPTK2)促进结直肠癌的增殖、迁移、侵袭和化疗耐药性。
Bioengineered. 2022 Jan;13(1):810-823. doi: 10.1080/21655979.2021.2012952.
7
Isoflurane Suppresses Proliferation, Migration, and Invasion and Facilitates Apoptosis in Colorectal Cancer Cells Through Targeting miR-216.异氟烷通过靶向miR-216抑制结肠癌细胞的增殖、迁移和侵袭并促进其凋亡。
Front Med (Lausanne). 2021 Aug 11;8:658926. doi: 10.3389/fmed.2021.658926. eCollection 2021.
8
Circ_DOCK1 regulates USP11 through miR-132-3p to control colorectal cancer progression.环状 RNA_DOCK1 通过 miR-132-3p 调控 USP11 以控制结直肠癌进展。
World J Surg Oncol. 2021 Mar 8;19(1):67. doi: 10.1186/s12957-021-02173-x.
9
LncRNA HOTAIR recruits SNAIL to inhibit the transcription of HNF4α and promote the viability, migration, invasion and EMT of colorectal cancer.长链非编码RNA HOTAIR招募SNAIL以抑制肝细胞核因子4α(HNF4α)的转录,并促进结直肠癌的生存、迁移、侵袭和上皮-间质转化。
Transl Oncol. 2021 Apr;14(4):101036. doi: 10.1016/j.tranon.2021.101036. Epub 2021 Feb 12.
10
Recent Insights into Therapy Resistance in Osteosarcoma.骨肉瘤治疗耐药性的最新见解
Cancers (Basel). 2020 Dec 30;13(1):83. doi: 10.3390/cancers13010083.